This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife and Amazon
Bear of the Day: Rite Aid (RAD)
by David Bartosiak
The competition is fierce and earnings are moving in the wrong direction
3 Retail Pharmacy and Drugstore Stocks to Watch Amid Pandemic Woes
by Urmimala Biswas
The Zacks Retail Pharmacy and Drugstore industry is gaining from growing demand for digital healthcare support. Industry players CVS, WBA and HLF are set to gain the most. However, Amazon's entry threat disrupts this uptrend.
Amazon's Physical Pharmacy Not a Grave Threat: 3 Stocks to Buy
by Urmimala Biswas
Investors should not lose optimism and continue to discover the enormous business opportunities this retail pharmacy- drug store industry holds. Here are three stocks, WMT, UNH, HLF, which you can grab now.
Surging Earnings Estimates Signal Upside for Herbalife LTD. (HLF) Stock
by Zacks Equity Research
Herbalife LTD. (HLF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
4 Sector ETFs & Stocks to Shine Despite Soft April Retail Sales
by Sanghamitra Saha
Retail sales in the United States were unchanged in April 2021, falling shy of market expectations of a 1% increase.
4 Must-Buy Efficient Stocks to Enrich Your Portfolio
by Tirthankar Chakraborty
Crocs (CROX), MEDIFAST (MED), Golden Entertainment (GDEN) and Herbalife (HLF) are the top companies that at present have favorable efficiency level and thus are expected to provide stellar returns.
Here is Why Growth Investors Should Buy Herbalife LTD. (HLF) Now
by Zacks Equity Research
Herbalife LTD. (HLF) possesses solid growth attributes, which could help it handily outperform the market.
Zacks.com featured highlights include: Herbalife, DaVita, Apple, Century Communities and Repligen Corp
by Zacks Equity Research
Zacks.com featured highlights include: Herbalife, DaVita, Apple, Century Communities and Repligen Corp
Herbalife LTD. (HLF) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Herbalife LTD. (HLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
5 of the Best Stocks to Buy Now for Striking Earnings Growth
by Tirthankar Chakraborty
Herbalife (HLF), DaVita (DVA), Apple (AAPL), Century Communities (CCS) & Repligen (RGEN) are the top stocks that flaunt attractive earnings growth at present.
Herbalife LTD. (HLF) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of 33.96% and 5.04%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
by Zacks Equity Research
Zacks Industry Outlook Highlights: CVS Health, Walgreen Boots, Herbalife, Rite Aid and Amazon
3 Pharmacies & Drugstore Stocks to Watch Amid COVID-19 Resurgence
by Urmimala Biswas
Despite severe COVID-19 challenges, higher demand for telemedicine and federal collaborations for vaccine rollout are likely to lend support to the Zacks Retail - Pharmacies and Drug Stores industry. HLF is well positioned to gain now while CVS and RAD hold huge prospects.
Herbalife LTD. (HLF) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Herbalife LTD. (HLF) delivered earnings and revenue surprises of -13.41% and -1.52%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Here is Why Growth Investors Should Buy Herbalife LTD. (HLF) Now
by Zacks Equity Research
Herbalife LTD. (HLF) could produce exceptional returns because of its solid growth attributes.
Walgreens (WBA) and UBER Tie Up to Expand COVID Vaccine Access
by Zacks Equity Research
Walgreens (WBA) and UBER to provide up to 10 million free or discounted rides to underserved communities.
Herbalife LTD. (HLF) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Herbalife LTD. (HLF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Herbalife, Toll Brothers and Exxon Mobil
by Zacks Equity Research
Zacks.com featured highlights include: Herbalife, Toll Brothers and Exxon Mobil
3 Stocks to Keep an Eye on for Solid Earnings Acceleration
by Tirthankar Chakraborty
Herbalife (HLF), Toll Brothers (TOL) and Exxon Mobil (XOM) are some of the few stocks that at present boast superb earnings acceleration.
Earnings Estimates Moving Higher for Herbalife LTD. (HLF): Time to Buy?
by Zacks Equity Research
Herbalife LTD. (HLF) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
New Strong Buy Stocks for January 29th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
New Strong Buy Stocks for January 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
Is Herbalife LTD. (HLF) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Herbalife LTD. (HLF) possesses solid growth attributes, which could help it handily outperform the market.
4 Momentum Stocks to Explore the Lucrative Driehaus Strategy
by Nitish Marwah
Investors who have the propensity to take a higher risk can think of investing in momentum stocks to boost their gains.